Detection of experimental hepatic tumors using long circulating superparamagnetic particles

Sayegh, Yasmine Alexandra; Pochon, S; Vallée, Jean-Paul; Becker, Minerva; Lazeyras, François; Tournier, H; Hyacinthe, R; Fouillet, X; Terrier, François

doi:10.1097/00004424-200101000-00003

Scientific article

English

Detection of experimental hepatic tumors using long circulating superparamagnetic particles

ContributorsSayegh, Yasmine Alexandra; Pochon, S; Vallée, Jean-Paul

; Becker, Minerva; Lazeyras, François; Tournier, H; Hyacinthe, R; Fouillet, X; Terrier, François

Published inInvestigative radiology, vol. 36, no. 1, p. 15-21

Publication date2001

Abstract

To evaluate the potential of an iron oxide-based MR contrast agent for the detection and delineation of experimental liver tumors during the early vascular phase of the compound.

Keywords

Animals
Contrast Media
Ferric Compounds/diagnostic use
Ferrosoferric Oxide
Liver Neoplasms/pathology
Magnetic Resonance Imaging
Neoplasms, Experimental/pathology
Rabbits

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de radiologie et informatique médicale

Research groups

Groupe Becker Minerva (imagerie ORL) (683)

Citation (ISO format)

SAYEGH, Yasmine Alexandra et al. Detection of experimental hepatic tumors using long circulating superparamagnetic particles. In: Investigative radiology, 2001, vol. 36, n° 1, p. 15–21. doi: 10.1097/00004424-200101000-00003

Article (Published version)

Identifiers

PID : unige:40418
DOI : 10.1097/00004424-200101000-00003
PMID : 11176257

Journal ISSN0020-9996

611views

0downloads

Creation25/08/2014 12:56:00

First validation25/08/2014 12:56:00

Update time14/03/2023 21:47:20

Status update14/03/2023 21:47:19

Last indexation30/10/2024 20:07:56

Archive ouverte UNIGE

Detection of experimental hepatic tumors using long circulating superparamagnetic particles

To evaluate the potential of an iron oxide-based MR contrast agent for the detection and delineation of experimental liver tumors during the early vascular phase of the compound.

Technical informations